These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 19097868)

  • 1. Pharmacokinetics and tolerance of linezolid for meticillin-resistant Staphylococcus aureus mediastinitis in paediatric patients.
    Kosaka T; Kokufu T; Shime N; Sugioka N; Kato R; Hamaoka K; Fujita N
    Int J Antimicrob Agents; 2009 Apr; 33(4):368-70. PubMed ID: 19097868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linezolid for the treatment of methicillin-resistant Staphylococcus aureus infections in children.
    Kaplan SL; Afghani B; Lopez P; Wu E; Fleishaker D; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
    Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S178-85. PubMed ID: 14520144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of linezolid in the treatment of mediastinitis due to methicillin-resistant Staphylococcus aureus: an experimental study.
    Sacar M; Sacar S; Kaleli I; Cevahir N; Teke Z; Kavas ST; Asan A; Aytekin FO; Baltalarli A; Turgut H
    Int J Infect Dis; 2008 Jul; 12(4):396-401. PubMed ID: 18162429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system].
    Jahoda D; Nyc O; Pokorný D; Landor I; Sosna A
    Acta Chir Orthop Traumatol Cech; 2006 Oct; 73(5):329-33. PubMed ID: 17140514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of mediastinitis due to methicillin-resistant Staphylococcus aureus in a renal dysfunction patient undergoing adjustments to the linezolid dose.
    Tsuji Y; Tashiro M; Ashizawa N; Ota Y; Obi H; Nagura S; Narukawa M; Fukahara K; Yoshimura N; To H; Yamamoto Y
    Intern Med; 2015; 54(2):235-9. PubMed ID: 25743019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Conservative treatment of a hip prosthesis infection due to methicillin-resistant Staphylococcus aureus using prolonged antibiotic therapy based on linezolid followed by daptomycin].
    Grossi O; Talarmin JP; Boutoille D; Frioux R; Corvec S; Raffi F
    Med Mal Infect; 2008 Dec; 38 Spec No 2():10-2. PubMed ID: 19185203
    [No Abstract]   [Full Text] [Related]  

  • 7. [A case of refractory deep incisional surgical site infection due to methicillin-resistant Staphylococcus aureus (MRSA) and successfully treated with oral linezolid].
    Matsumoto H; Kawabata R; Kishimoto T; Yamamoto E; Kimura Y; Imamura H; Yamamoto T; Takemoto H; Fukunaga M; Ohzato H
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):2441-3. PubMed ID: 23268104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical efficacy of oral linezolid compared with intravenous vancomycin for the treatment of methicillin-resistant Staphylococcus aureus-complicated skin and soft tissue infections: a retrospective, propensity score-matched, case-control analysis.
    Itani KM; Biswas P; Reisman A; Bhattacharyya H; Baruch AM
    Clin Ther; 2012 Aug; 34(8):1667-73.e1. PubMed ID: 22770644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and pharmacodynamics of linezolid, alone and in combination with rifampicin, in an experimental model of methicillin-resistant Staphylococcus aureus endocarditis.
    Tsaganos T; Skiadas I; Koutoukas P; Adamis T; Baxevanos N; Tzepi I; Pelekanou A; Giamarellos-Bourboulis EJ; Giamarellou H; Kanellakopoulou K
    J Antimicrob Chemother; 2008 Aug; 62(2):381-3. PubMed ID: 18445576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linezolid reduces length of stay and duration of intravenous treatment compared with vancomycin for complicated skin and soft tissue infections due to suspected or proven methicillin-resistant Staphylococcus aureus (MRSA).
    Itani KM; Weigelt J; Li JZ; Duttagupta S
    Int J Antimicrob Agents; 2005 Dec; 26(6):442-8. PubMed ID: 16289514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linezolid in the treatment of methicillin-resistant staphylococcal post-neurosurgical meningitis: a series of 17 cases.
    Sipahi OR; Bardak S; Turhan T; Arda B; Pullukcu H; Ruksen M; Aydemir S; Dalbasti T; Yurtseven T; Zileli M; Ulusoy S
    Scand J Infect Dis; 2011 Oct; 43(10):757-64. PubMed ID: 21671825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of linezolid in 16 infants and children in Japan.
    Shinjoh M; Iketani O; Watanabe K; Shimojima N; Kudo M; Yamagishi H; Shimada H; Sugita K; Takahashi T; Mori T; Hasegawa N; Iwata S
    J Infect Chemother; 2012 Aug; 18(4):591-6. PubMed ID: 22460827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and pharmacodynamics of linezolid in children with cystic fibrosis.
    Santos RP; Prestidge CB; Brown ME; Urbancyzk B; Murphey DK; Salvatore CM; Jafri HS; McCracken GH; Ahmad N; Sanchez PJ; Siegel JD
    Pediatr Pulmonol; 2009 Feb; 44(2):148-54. PubMed ID: 19137597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the pharmacokinetics of linezolid in an obese Japanese patient.
    Tsuji Y; Hiraki Y; Matsumoto K; Mizoguchi A; Sadoh S; Kobayashi T; Sakamoto S; Morita K; Yukawa E; Kamimura H; Karube Y
    Scand J Infect Dis; 2012 Aug; 44(8):626-9. PubMed ID: 22263918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linezolid for the treatment of infections caused by Gram-positive pathogens in China.
    Lin DF; Zhang YY; Wu JF; Wang F; Zheng JC; Miao JZ; Zheng LY; Sheng RY; Zhou X; Shen HH; Ijzerman MM; Croos-Dabrera RV; Sheng W
    Int J Antimicrob Agents; 2008 Sep; 32(3):241-9. PubMed ID: 18635341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linezolid versus teicoplanin in the treatment of Gram-positive infections in the critically ill: a randomized, double-blind, multicentre study.
    Cepeda JA; Whitehouse T; Cooper B; Hails J; Jones K; Kwaku F; Taylor L; Hayman S; Shaw S; Kibbler C; Shulman R; Singer M; Wilson AP
    J Antimicrob Chemother; 2004 Feb; 53(2):345-55. PubMed ID: 14711840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linezolid for tympanostomy tube otorrhea caused by methicillin-resistant Staphylococcus aureus and multiple drug-resistant Streptococcus pneumoniae.
    Isaacson G; Aronoff SC
    Int J Pediatr Otorhinolaryngol; 2008 May; 72(5):647-51. PubMed ID: 18321598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma exposure of free linezolid and its ratio to minimum inhibitory concentration varies in critically ill patients.
    Yagi T; Naito T; Doi M; Nagura O; Yamada T; Maekawa M; Sato S; Kawakami J
    Int J Antimicrob Agents; 2013 Oct; 42(4):329-34. PubMed ID: 23988716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum and sputum concentrations following the oral administration of linezolid in adult patients with cystic fibrosis.
    Saralaya D; Peckham DG; Hulme B; Tobin CM; Denton M; Conway S; Etherington C
    J Antimicrob Chemother; 2004 Feb; 53(2):325-8. PubMed ID: 14729733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized, double-blind comparison of once-weekly dalbavancin versus twice-daily linezolid therapy for the treatment of complicated skin and skin structure infections.
    Jauregui LE; Babazadeh S; Seltzer E; Goldberg L; Krievins D; Frederick M; Krause D; Satilovs I; Endzinas Z; Breaux J; O'Riordan W
    Clin Infect Dis; 2005 Nov; 41(10):1407-15. PubMed ID: 16231250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.